Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 6 A, 2006, Pages 435-440

  Kelter, Gerhard ^a   Fiebig, Heinz Herbert ^a  

^a CHARLES RIVER LABORATORIES   (United States)

Author keywords

Iscador ; Mistletoe extracts, antitumor activity, human tumor cell lines, stimulation of tumor growth; Viscum album L.

Indexed keywords

LECTIN; VISCUM ALBUM EXTRACT; ANTINEOPLASTIC AGENT; COLORING AGENT; LISSAMINE RHODAMINE B; PLANT EXTRACT; PROPIDIUM IODIDE; RHODAMINE; VEGETABLE PROTEIN; VISCUM ALBUM PEPTIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; TUMOR CELL; TUMOR GROWTH; DOSE RESPONSE; DRUG EFFECT; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PLANT EXTRACTS; PLANT PROTEINS; PROPIDIUM; RHODAMINES;

EID: 33748641369     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296809     Document Type: Article

References (21)

1. Bocci, V, Mistletoe (Viscum album) lectins as Cytokine Inducers and Immunoadjuvant in Tumor Therapy. A Review. J. Biol. Regul. Homeost. Agents 7, 1 (1993)
2. Beuth, J., Clinical Relevance of Immunoactive Mistletoe Lectin-I. Anticancer Drugs 8 (Suppl. 1), 53 (1997)
3. Grossarth-Maticek, R., Kiene, H., Baumgartner, S. M. et al., Use of Iscador, an Extract of European Mistletoe (Viscum album), in Cancer Treatment: Prospective Nonrandomized and Randomized Matched-Pair Studies Nested within a Cohort Study. Altern. Then Health Med. 7, 57, 68, 74 (2001)
4. Witthohn, K., Schwarz, T., Qualität von Mistelextrakten. In: Loew, D., Blume, H., Dingermann, T.(eds.); Phytopharmaka, V, Forschung und Klinische Anwendung, pp. 19-26, Steinkopff Verlag, Darmstadt (1999)
5. Janssen, O., Scheffler, A., Kabelitz, D., In vitro Effects of Mistletoe Extracts and Mistletoe Lectins. Cytotoxicity towards Tumor Cells due to Induction of Programmed Cell Death (Apoptosis). Arzneim.-Forsch./Drug Res. 43, 1221 (1993)
6. Bussing, A., Schietzel, M., Apoptosis-Inducing Properties of Viscum album L. Extracts from Different Host Trees, Correlate with Their Content of Toxic Mistletoe Lectins. Anticancer Res. 19, 23 (1999)
7. Maier, G., Fiebig, H. H., Absence of Tumor Growth Stimulation in a Panel of 16 Human Tumor Cell Lines by Mistletoe Extracts in vitro. Anticancer Drugs 13, 373 (2002)
8. Burger, A. M., Mengs, U., Schuler, J. B. et al., Antiproliferative Activity of an Aqueous Mistletoe Extract in Human Tumor Cell Lines and Xenografts in vitro. Arzneim.-Forsch./Drug Res. 51, 748 (2001)
9. Burger, A. M., Mengs, U., Schuler, J. B. et al., Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models. Anticancer Res. 21, 1965 (2001)
10. Hajto, T, Hostanska, K., Gabius, H. I., Modulatory Potency of the β-Galactoside-specific Lectin from Mistletoe Extract (Iscador) on the Host Defense System in Vivo in Rabbits and Patients. Cancer Res. 49, 4803 (1989)
11. Schink, M., Mistletoe Therapy for Human Cancer: the Role of Natural Killer Cells. Anticancer Drugs 8 (Suppl. 1), 47 (1997)
12. Elsässer-Beile, U., Voss, M., Schuhle, R. et al., Biological Effects of Natural and Recombinant Mistletoe Lectin and an Aqueous Mistletoe Extract on Human Monocytes and Lymphocytes in Vitro. J. Clin. Lab. Anal. 14, 255 (2000)
13. Hajto, T., Hostanska, K., Frei, K. et al., Increased Secretion of Tumor Necrosis Factor-α, Interleukin-1, and Interleukin-6 by Human Mononuclear Cells Exposed to β-Galactoside-specific Lectin from Clinically Applied Mistletoe Extract. Cancer Res. 50, 3322 (1990)
14. Ribereau-Gayon, G., Dumont, S., Muller, C. et al., Mistletoe Lectins I, II, III Induce the Production of Cytokines by Cultured Human Monocytes. Cancer Lett. 109, 33 (1996)
15. Joller, P. W., Menrad, J. M., Schwarz, T., et al., Stimulation of Cytokine Production via a Special Standardized Mistletoe Preparation in an in vitro Human Skin Bioassay. Arzneim.-Forsch./Drug Res. 46, 649 (1996)
16. Rüdiger, H., Gabius, S., Gabius, H. J., Von der Diabetestherapie mit Glucobay® zur alternativen Krebsbehandlung mit Mistelextrakt. Z. Phytotherapie 22, 182 (2001)
17. Hagenah, W., Dorges, L, Gafumbegete, E. et al., Subcutaneous Manifestations of a Centrocytic Non-Hodgkin Lymphoma at the Injection Site of a Mistletoe Preparation. Dtsch. Med. Wochenschr. 123, 1001 (1998)
18. Gabius, H. J., Darro, E, Remmelink, M. et al., Evidence for Stimulation of Tumor Proliferation in Cell Lines and Histotypic Cultures by Clinically Relevant Low Doses of the Galactoside-Binding Mistletoe Lectin, A Component of Proprietary Extracts. Cancer Invest. 19, 114 (2001)
19. Roth, T., Burger, A. M., Dengler, W. A. et al., Human tumor cell lines demonstrating the characteristics of patient tumors as useful models for anticancer drug screening. In: Fiebig, H. H., Burger, A. M. (eds.), Relevance of Tumor Models for Anticancer Drug Development, Contrib. Oncol. 54, pp. 145-156, Karger, Basel (1999)
20. Dengler, W. A., Schulte, J., Berger, D. P. et al., Development of a Propidium Iodide Fluorescence Assay for Proliferation and Cytotoxicity Assays. Anticancer Drugs 6, 522 (1995)
21. Skehan, P., Storeng, R., Scudiero, D. et al., New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. J. Natl. Cancer Inst. 82, 1107 (1990)